Author

A. Debnath

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

C. Sauvey· 2 shared G. Ehrenkaufer· 2 shared R. Abagyan· 2 shared A. Altieri· 1 shared A. Drelich· 1 shared A. Kurkin· 1 shared B. Raman· 1 shared C. Hillyer· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Sauvey

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Neuronal Maturation-dependent Nano-Neuro Interaction and Modulation

P. Gupta, P. Rathi, R. Gupta, H. Baldi, Q. Coquerel, A. Debnath, H. Gholami Derami, B. Raman, S. Singamaneni

This study investigates nano-neuro interactions during neural network maturation, finding that nanoparticle density correlates with neuronal maturation stage and results in heterogeneous optical neuromodulation.

bioRxiv · Aug 3, 2022Bioengineering

Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta)

F. Curreli, S. Ahmed, S. M. B. Victor, A. Drelich, S. S. Panda, A. Altieri, A. Kurkin, C.-T. Tseng, C. Hillyer, A. Debnath

The paper identifies potent small molecules that inhibit multiple coronaviruses, including SARS-CoV-2 variants, with high selectivity and in vivo efficacy.

bioRxiv · Sep 3, 2021Pharmacology & Toxicology

Antineoplastic kinase inhibitors: a new class of potent anti-amoebic compounds

C. Sauvey, G. Ehrenkaufer, D. Shi, A. Debnath, R. Abagyan

This study identifies six FDA-approved antineoplastic kinase inhibitors with potent anti-amoebic activity against Entamoeba histolytica, including one drug effective against both trophozoites and cysts.

bioRxiv · May 28, 2020Microbiology

Antimalarial drug mefloquine kills both trophozoite and cyst stages of Entamoeba

C. Sauvey, G. Ehrenkaufer, A. Debnath, R. Abagyan

This study shows mefloquine is more effective and faster than metronidazole in killing both trophozoite and cyst stages of Entamoeba parasites.

bioRxiv · Dec 20, 2018 · PreprintPharmacology & Toxicology